- Company approved to expand Liberty 360
Innovation Campus cultivation space in Gainesville to 228,880
TORONTO , April 3, 2019 /CNW/ - Liberty Health
Sciences Inc. (LHS.CN) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty"
or the "Company"), a provider of high quality cannabis, announced
today that it will open its 13th Florida dispensary in Bonita
Springs on April 5 th, as the company continues to
expand rapidly throughout the state. On April 1 st the
Company also received approval form the Florida Department of
Health (DOH) for an additional use of 80,000 square feet of
enclosed greenhouse space at the Liberty 360 Innovation campus in
Gainesville . This brings the Company to a total of 228,880 square
feet of cultivation space in the Gainesville area.
This comes on the heels of the Company receiving
approval last week to become one of the first companies to provide
pre-roll and whole flower smokable products to patients as a result
of Governor Ron DeSantis signing a bill (SB 182) into law revoking
a ban on smokable medical marijuana.
Located at 24611 Production Circle Bonita
Springs, Bonita Springs, FL , off of Tamiami Trail, also known as
Alligator Alley, the new dispensary is open Monday through Friday,
10 a.m. to 7 p.m. , Saturday, 10 a.m. to 5 p.m. , and Sunday 12
p.m. to 5 p.m. The 4,000 square-foot facility includes innovative
shopping displays that engage and educate patients, two private
consultation rooms and two private waiting rooms where patients,
physicians and community members can learn about the benefits of
medical cannabis in a relaxed and secure environment.
"Each day Liberty works to help our patients live
the life they deserve through our commitment to provide them access
to the highest quality medicinal cannabis," said Victor E. Mancebo
, interim Chief Executive Officer of Liberty . "We are excited to
open the doors to our patients in Bonita Springs and serve our
patients in Lee County . This location will mark Liberty's first
location in the Southwest region of the state. Many patients have
inquired about a dispensary in this region, and this dispensary
highlights Liberty's commitment in promoting the accessibility of
medical cannabis to the Florida patient community."
Liberty currently operates 12 dispensaries in the
following cities across Florida :
â¢ Dania Beach
â¢ Merritt Island
â¢ North Miami
â¢ Palm Harbor
â¢ Port St. Lucie
â¢ St. Petersburg
â¢ Tampa (Hyde Park)
â¢ Orange Park
â¢ Winter Haven
Patients may place an order online at www.libertyhealthsciences.com for
in-store pick-up or free delivery. Liberty also offers patients
free delivery statewide.
About Liberty Health Sciences Inc.
Liberty is the cannabis provider committed to providing a trusted,
high quality cannabis experience based on our genuine care for all
cannabis users and a focus on operational excellence from seed to
sale. Liberty's measured approach to expansion opportunities is
focused on maximizing returns to shareholders, while keeping
consumers' well-being at the forefront of what we do. For more
information, please visit: www.libertyhealthsciences.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS: This press release contains certain forward-looking
statements within the meaning of applicable securities laws. Any
statements that are contained in this news release that are not
statements of historical fact may be deemed to be forward-looking
statements. Forward-looking statements are often identified by
terms such as "may", "should", "anticipate", "expect", "believe",
"plan", "intend" or the negative of these terms and similar
expressions. Forward-looking statements in this news release
include, but are not limited to, expectations related to the
Company's production capabilities, expectations concerning the
receipt of all necessary approvals from the Florida Department of
Health, expectations concerning the opening of new dispensaries and
the expansion of its greenhouse space, and the Company's future
expansion and growth strategies. Forward-looking statements
necessarily involve known and unknown risks, including, without
limitation, risks associated with general economic conditions;
adverse industry events; marketing costs; loss of markets; future
legislative and regulatory developments involving medical
marijuana; inability to access sufficient capital from internal and
external sources, and/or inability to access sufficient capital on
favorable terms; the medical marijuana industry in the United
States generally, income tax and regulatory matters; the ability of
Liberty to implement its business strategies; competition; crop
failure; currency and interest rate fluctuations and other risks.
Readers are cautioned that the foregoing list is not exhaustive.
Readers are further cautioned not to place undue reliance on
forward-looking statements as there can be no assurance that the
plans, intentions or expectations upon which they are placed will
occur. Such information, although considered reasonable by
management at the time of preparation, may prove to be incorrect
and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are
expressly qualified by this cautionary statement.
View original content to download
SOURCE Liberty Health Sciences Inc.
View original content to download multimedia: